RECRUITING

Study on the Compensatory Mechanism of Iodine Nutrition and the Optimal Intake Level of Lactating Women

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Due to the lack of direct evidence of optimal iodine intake of Chinese children, pregnant and lactating women and infants were found during the recent revision of Chinese dietary reference intakes (DRIs) of iodine in 2013 by the applicant Pro. Zhang, and no systematical research about compensatory mechanism of iodine nutrition in lactating women was found yet. Previous study funded by United Nations International Children's Emergency Fund (UNICEF) cooperated with the international experts on iodine and key project of national natural science foundation of China under the guidance of Pro. Zhang, had obtained the safe intake range of iodine from children and pregnant women, more than 10 joint papers were published, which laid the foundation of population study and international cooperation.

Official Title

Study on the Compensatory Mechanism of Iodine Nutrition and the Optimal Intake Level of Lactating Women

Quick Facts

Study Start:2020-01-01
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04492657

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:1 Day to 40 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Women in their third trimester:⑴Aged 18-40, who have lived in the area for 1 year;⑵Single pregnancy;⑶Those who have no special dietary habits;
  2. * Lactating woman:⑴Breastfeeding a child;⑵Normal thyroid function during pregnancy;⑶Term delivery (38-42 weeks of gestation);
  3. * Infants and young children:⑴0-6 months;⑵Breastfeeding;⑶Full term (38-42 weeks of gestation);⑷Normal birth weight (2500-4000g);⑸The thyroid-stimulating hormone (TSH) value of heel blood was normal;⑹Apgar score 8.
  1. * Women in their third trimester:⑴Smoking or drinking;⑵Iodized drugs or contrast agents have been used in the past year;⑶A history of thyroid disease, autoimmune disease, endocrine disease, heart disease, chronic disease or family hereditary disease, etc;
  2. * Lactating woman:⑴A history of thyroid disease, autoimmune disease, endocrine disease, heart disease, chronic disease or family hereditary disease, etc;
  3. * Infants and young children:⑴Have pathological jaundice, autoimmune disease, congenital heart disease and other diseases.

Contacts and Locations

Study Contact

WanQi Zhang, doctorate
CONTACT
022-83336595
wqzhang@tmu.edu.cn
ying Ye
CONTACT
022-83336717
yeying@tmu.edu.cn

Principal Investigator

JianQiang Lai
PRINCIPAL_INVESTIGATOR
Institute of Nutrition and Health, Chinese Center for Disease Control and Prevention
XueSong Wang
PRINCIPAL_INVESTIGATOR
Shandong Institute of Endemic Disease Control and Prevention
YiFan Duan
PRINCIPAL_INVESTIGATOR
Institute of Nutrition and Health, Chinese Center for Disease Control and Prevention
GuiJun Tan
PRINCIPAL_INVESTIGATOR
Tianjin Medical University
Wen Chen
PRINCIPAL_INVESTIGATOR
Tianjin Medical University
YanTing Chen
PRINCIPAL_INVESTIGATOR
Tianjin Medical University
Min Gao
PRINCIPAL_INVESTIGATOR
Tianjin Medical University
ZiYun Pan
PRINCIPAL_INVESTIGATOR
Tianjin Medical University
Michael B Zimmermann, doctorate
STUDY_CHAIR
Swiss federal institute of Technology (ETH)
Elizabeth N Pearce, doctorate
STUDY_CHAIR
Boston University School of Medicine; Iodine Global Network (IGN)
Maria Andersson, doctorate
STUDY_CHAIR
Swiss federal institute of Technology (ETH); Iodine Global Network (IGN)

Study Locations (Sites)

Boston University School of Medicine; Iodine Global Network (IGN)
Boston, Massachusetts, 02101-02117
United States

Collaborators and Investigators

Sponsor: Tianjin Medical University

  • JianQiang Lai, PRINCIPAL_INVESTIGATOR, Institute of Nutrition and Health, Chinese Center for Disease Control and Prevention
  • XueSong Wang, PRINCIPAL_INVESTIGATOR, Shandong Institute of Endemic Disease Control and Prevention
  • YiFan Duan, PRINCIPAL_INVESTIGATOR, Institute of Nutrition and Health, Chinese Center for Disease Control and Prevention
  • GuiJun Tan, PRINCIPAL_INVESTIGATOR, Tianjin Medical University
  • Wen Chen, PRINCIPAL_INVESTIGATOR, Tianjin Medical University
  • YanTing Chen, PRINCIPAL_INVESTIGATOR, Tianjin Medical University
  • Min Gao, PRINCIPAL_INVESTIGATOR, Tianjin Medical University
  • ZiYun Pan, PRINCIPAL_INVESTIGATOR, Tianjin Medical University
  • Michael B Zimmermann, doctorate, STUDY_CHAIR, Swiss federal institute of Technology (ETH)
  • Elizabeth N Pearce, doctorate, STUDY_CHAIR, Boston University School of Medicine; Iodine Global Network (IGN)
  • Maria Andersson, doctorate, STUDY_CHAIR, Swiss federal institute of Technology (ETH); Iodine Global Network (IGN)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-01-01
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2020-01-01
Study Completion Date2024-12-31

Terms related to this study

Keywords Provided by Researchers

  • public nutrition
  • nutrition of special population
  • lactating women and infants
  • physiological compensatory mechanism
  • iodine balance study

Additional Relevant MeSH Terms

  • Nutritional Requirements